Chrysalis BioTherapeutics Receives Additional Funding from the National Institutes of Health for COVID-19 Therapeutic Development
Round Type
Funding Round
GalvestonBiotechnologyHealthcareDescription
Chrysalis BioTherapeutics, Inc., a clinical-stage biotechnology company developing regenerative drugs that target vascular endothelial and progenitor cells, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has provided additional funding in the amount of $587,995 to its contract with Chrysalis, bringing the total contract award to develop TP508 as a therapeutic for COVID-19 patients to $1.5 million.
Quick answer
Chrysalis Bio Therapeutics raised an undisclosed amount in a Funding Round round, dated August 11, 2020. Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.
- How much did Chrysalis Bio Therapeutics raise?
- Chrysalis Bio Therapeutics raised an undisclosed amount in a Funding Round round on August 11, 2020.
- What does Chrysalis Bio Therapeutics do?
- Chrysalis BioTherapeutics, Inc. is a biopharmaceutical development company located in Galveston, TX.
- Where is Chrysalis Bio Therapeutics based and how big is it?
- Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.
- Who are the decision-makers at Chrysalis Bio Therapeutics?
- Fundz holds 2 contacts at Chrysalis Bio Therapeutics, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Chrysalis Bio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $500K on September 25, 2020.
- Eledon raised $108M on September 25, 2020.
- Vaccinex raised $2M (Seed) on September 16, 2020.
- Rain Therapeutics Inc. raised $73M on September 16, 2020.
- Recursion Pharmaceuticals raised $236M on September 15, 2020.
- CathBuddy raised $772K (Seed) on September 15, 2020.
Who to call at Chrysalis Bio Therapeutics, and when
A new round usually means Chrysalis Bio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Chrysalis Bio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Chrysalis Bio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Chrysalis Bio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Chrysalis Bio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Chrysalis Bio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.